A validation sampling approach for consistent estimation of adverse drug reaction risk with misclassified right‐censored survival data
- 6 August 2018
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 37 (27) , 3887-3903
Abstract
Patient electronic health records, viewed as continuous‐time right‐censored survival data, can be used to estimate adverse drug reaction risk. Temporal outcome misclassification may occur as a result of errors in follow‐up. These errors can be due to a failure to observe the incidence time of the adverse event of interest (due to misdiagnosis or nonreporting, etc) or an actual misdiagnosis of a competing adverse event. As the misclassifying event is often unobservable in the original data, we apply an internal validation sampling approach to produce consistent estimation in the presence of such errors. We introduce a univariate survival model and a cause‐specific hazards model in which misclassification may also manifest as a diagnosis of an alternate adverse health outcome other than that of interest. We develop a method of maximum likelihood estimation of the model parameters and establish consistency and asymptotic normality of the estimators using standard results. We also conduct simulation studies to numerically investigate the finite sample properties of these estimators and the impact of ignoring the misclassification error.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada
This publication has 12 references indexed in Scilit:
- A Flexible AFT Model for Misclassified Clustered Interval-Censored DataBiometrics, 2015
- Impact of and Correction for Outcome Misclassification in Cumulative Incidence EstimationPLOS ONE, 2015
- Accuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative dataAnnals of Epidemiology, 2013
- Use of electronic health record data to identify skin and soft tissue infections in primary care settings: a validation studyBMC Infectious Diseases, 2013
- Design and testing for clinical trials faced with misclassified causes of deathBiostatistics, 2010
- Misclassification of current status dataLifetime Data Analysis, 2010
- Incorporating validation subsets into discrete proportional hazards models for mismeasured outcomesStatistics in Medicine, 2008
- The Emergence of National Electronic Health Record Architectures in the United States and Australia: Models, Costs, and QuestionsJournal of Medical Internet Research, 2005
- Discrete Proportional Hazards Models for Mismeasured OutcomesBiometrics, 2003
- Product limit estimation for infectious disease data when the diagnostic test for the outcome is measured with uncertaintyBiostatistics, 2000